All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| ALDX / Aldeyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
| GH / Guardant Health, Inc.
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
| HNGR / Hanger Inc
|
|
|
|
|
|
|
|
| UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
| SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
| SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| TNET / TriNet Group, Inc.
|
|
|
|
|
|
|
|
| EOLS / Evolus, Inc.
|
|
|
|
|
|
|
|
| URGN / UroGen Pharma Ltd.
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ALLK / Allakos Inc. Put
|
|
|
|
|
|
|
|
| ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
| AXSM / Axsome Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
| NVST / Envista Holdings Corporation
|
|
|
|
|
|
|
|
| PRTK / Paratek Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ARQL / ArQule, Inc.
|
|
|
|
|
|
|
|
| FIXX / Homology Medicines, Inc.
|
|
|
|
|
|
|
|
| RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
| RETA / Reata Pharmaceuticals Inc - Class A Call
|
|
|
|
|
|
|
|
| CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
| UROV / Urovant Sciences Ltd
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| ACIU / AC Immune SA
|
|
|
|
|
|
|
|
| CI / The Cigna Group
|
|
|
|
|
|
|
|
| TPST / Tempest Therapeutics, Inc.
|
|
|
|
|
|
|
|
| EVH / Evolent Health, Inc.
|
|
|
|
|
|
|
|
| ADMA / ADMA Biologics, Inc.
|
|
|
|
|
|
|
|
| MIST / Milestone Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| PSNL / Personalis, Inc.
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc Call
|
|
|
|
|
|
|
|
| TLGT / Teligent Inc
|
|
|
|
|
|
|
|
| QURE / uniQure N.V.
|
|
|
|
|
|
|
|
| CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
| RCM / R1 RCM Inc.
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
| ZBH / Zimmer Biomet Holdings, Inc.
|
|
|
|
|
|
|
|
| HUM / Humana Inc.
|
|
|
|
|
|
|
|
| ORGO / Organogenesis Holdings Inc.
|
|
|
|
|
|
|
|
| ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
| CUE / Cue Biopharma, Inc.
|
|
|
|
|
|
|
|
| IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| CNC / Centene Corporation
|
|
|
|
|
|
|
|
| MGTX / MeiraGTx Holdings plc
|
|
|
|
|
|
|
|
| KZR / Kezar Life Sciences, Inc.
|
|
|
|
|
|
|
|
